Lv4
660 积分 2023-09-25 加入
Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia
17天前
已完结
Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML
1个月前
已完结
The bone marrow microenvironment – Home of the leukemic blasts
1个月前
已完结
Leukemia cell infiltration causes defective erythropoiesis partially through MIP-1α/CCL3
1个月前
已完结
Comparative efficacy and safety of eleven induction chemotherapy regimens for young adult patients with newly diagnosed acute myeloid leukemia: a network meta-analysis
1个月前
已完结
Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia
1个月前
已完结
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy
2个月前
已完结
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
2个月前
已完结
BCL-2 inhibition in haematological malignancies: Clinical application and complications
3个月前
已完结
Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia
3个月前
已完结
皖公网安备34019202002308
